DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operating Income | ₹2,227 Cr | ₹2,017 Cr | ₹2,087 Cr | ₹1,581 Cr | ₹1,330 Cr |
What is the latest Revenue of DR LAL PATHLABS ?
Year | Revenue |
---|---|
Mar2024 | ₹2,227 Cr |
Mar2023 | ₹2,017 Cr |
Mar2022 | ₹2,087 Cr |
Mar2021 | ₹1,581 Cr |
Mar2020 | ₹1,330 Cr |
How is Revenue of DR LAL PATHLABS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,227 Cr | 10.40 | |
Mar2023 | ₹2,017 Cr | -3.38 | |
Mar2022 | ₹2,087 Cr | 32.01 | |
Mar2021 | ₹1,581 Cr | 18.86 | |
Mar2020 | ₹1,330 Cr | - |
Compare Revenue of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹24,912.8 Cr | 0.2% | -3.3% | 15% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹98,334.3 Cr | 3.5% | 0.6% | 27.9% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹95,006.5 Cr | 1.7% | 7.3% | 59.9% | Stock Analytics | |
FORTIS HEALTHCARE | ₹49,098.7 Cr | -5.2% | 10.6% | 81.8% | Stock Analytics | |
GLOBAL HEALTH | ₹28,904.0 Cr | 0.4% | 1.5% | 23.1% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,517.5 Cr | 0.3% | 2.1% | 1.4% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | 0.2% |
-3.3% |
15% |
SENSEX | 2.5% |
-0.5% |
19.7% |
You may also like the below Video Courses